Agios Pharmaceuticals AGIO Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's total current liabilities?
- Agios Pharmaceuticals (AGIO) reported total current liabilities of $58.85M in Q1 2026.
- How has Agios Pharmaceuticals's total current liabilities changed year-over-year?
- Agios Pharmaceuticals's total current liabilities increased by 12.4% year-over-year, from $52.37M to $58.85M.
- What is the long-term trend for Agios Pharmaceuticals's total current liabilities?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's total current liabilities has grown at a -2.7% compound annual growth rate (CAGR), from $94.39M to $82.21M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.